Company: KAVL
Filing Date: 2025-08-18
Form Type: 424B5
Source: 0001731122-25-001141
Chunk: 1

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-08-18
Form: 424B5
Chunk 1
---
 also agreed to provide indemnification and contribution to Maxim with respect to certain liabilities,
including liabilities under the Securities Act.

As of the date of this prospectus
supplement, the aggregate market value of our outstanding common stock held by non-affiliates, or public float, was approximately
$4,660,608 based on 5,616,544 shares of our outstanding common stock that were held by non-affiliates on such date and a price of
$0.8298 per share, which was the price at which our common stock was last sold on the Nasdaq Capital Market on August 15, 2025
calculated in accordance with General Instruction I.B.6 of Form S-3. Pursuant to General Instruction I.B.6 of Form S-3, in no event
will we sell shares of our common stock pursuant to this prospectus supplement with a value of more than one-third of the aggregate
market value of our common stock held by non-affiliates in any 12-month period, so long as the aggregate market value of our common
stock held by non-affiliates is less than $75,000,000. We have not offered any securities pursuant to General Instruction I.B.6 of
Form S-3 during the twelve-month period that ends on and includes the date hereof. After giving effect to these limitations and the
current public float of our common stock, and after giving effect to the terms of the Sales Agreement, we currently may offer and
sell shares of our common stock having an aggregate offering price of up to $1,553,536 under the Sales Agreement.

Our common stock is listed on The Nasdaq
Capital Market under the symbol “KAVL.” On August 15, 2025, the last reported sale price of our common stock was $0.8298
per share. Currently,

we are an “emerging growth company” as
defined in Section 2(a) of the Securities Act of 1933, as amended, and are subject to reduced public company reporting requirements.
Please read “Implications of Being an Emerging Growth Company” beginning on page S-5 of this prospectus supplement.

Investing in our common stock involves a high degree of risk. Before making an investment decision, please read the information under the heading “Risk Factors” beginning on page S-7 of this prospectus supplement, page 12 of the accompanying base prospectus and similar headings in the documents incorporated by reference into this prospectus supplement